You shouldn't see thisYou may have access to the free features available through My Research. You can save searches, save documents, create alerts and more. Please log in through your library or institution to check if you have access.

If you log in through your library or institution you might have access to this article in multiple languages.

Styles include MLA, APA, Chicago and many more. This feature may be available for free if you log in through your library or institution.

You may have access to it for free by logging in through your library or institution.

You may have access to different export options including Google Drive and Microsoft OneDrive and citation management tools like RefWorks and EasyBib. Try logging in through your library or institution to get access to these tools.

Abstract We set out to discern to what extent the media strategies adopted around the vaccines against covid19 during the first 15 months since the beginning of their application can be considered as a legitimate and coherent contributions to a better understanding about their performance and to what extent the elaborated discourses could respond to the economic interests of the corporations’ elites. Once the most relevant elements that have shaped the predominant narratives from the moment the vaccines were conceived were compiled, several anomalies were identified that were to a greater or lesser extent invisibilized in the process of their approval and the results of their application. The most significant of these concern the handling of definitions, noncompliance with commitments and conflicts of interest that compromise the actions of vaccine marketing companies and regulatory bodies. Many elements related to corporative interests have influenced the narrative concerning vaccines. Among those that require a resignification are: their real preventive capacity against contagions, serious diseases and deaths, their efficacy against new variants, the duration of the immunity they confer, their side effects, the synergic role of acquired immunity, and the resources used by the companies to achieve a virtually market monopolistic predominance
We set out to discern to what extent the media strategies adopted around the vaccines against covid19 during the first 15 months since the beginning of their application can be considered as a legitimate and coherent contributions to a better understanding about their performance and to what extent the elaborated discourses could respond to the economic interests of the corporations’ elites. Once the most relevant elements that have shaped the predominant narratives from the moment the vaccines were conceived were compiled, several anomalies were identified that were to a greater or lesser extent invisibilized in the process of their approval and the results of their application. The most significant of these concern the handling of definitions, noncompliance with commitments and conflicts of interest that compromise the actions of vaccine marketing companies and regulatory bodies. Many elements related to corporative interests have influenced the narrative concerning vaccines. Among those that require a resignification are: their real preventive capacity against contagions, serious diseases and deaths, their efficacy against new variants, the duration of the immunity they confer, their side effects, the synergic role of acquired immunity, and the resources used by the companies to achieve a virtually market monopolistic predominance
ropomonos discernir em que medida as estratégias mediáticas adotadas em torno das vacinas covid19, ao longo dos primeiros 15 meses desde o início da sua aplicação, podem dar contribuições legítimas e coerentes para melhor compreender o seu desempenho, e em que medida as narrativas poderiam responder aos interesses econômicos das elites corporativas. Uma vez compilados os elementos mais relevantes com os quais se configuram as narrativas predominantes desde o momento em que as vacinas foram concebidas, foram identificadas diversas anomalias que foram, em maior ou menor medida, invisibilizadas no processo de sua aprovação e nos resultados de sua aplicação . As mais significativas dizem respeito à gestão de definições, descumprimentos de compromissos e conflitos de interesse que comprometem a atuação das empresas comercializadoras e dos órgãos reguladores das vacinas. Inúmeros elementos relacionados a interesses corporativos gravitaram na elaboração da história sobre vacinas. Entre os que demandam ressignificação estão: sua real capacidade preventiva de contágios, evoluções graves e óbitos, sua eficácia contra novas variantes, a duração da imunidade que se consolidou, seus efeitos adversos, o papel sinérgico da imunidade adquirida e os recursos utilizados. empresas para alcançar o domínio do monopólio virtual no mercado.
Title
Reflexiones acerca de las cambiantes narrativas sobre las vacunas contra la COVID-19
Author
Silva Ayçaguer, Luis Carlos

; Andrés Bloch Silva
Section
Condiciones de salud
Publication date
Sep-Dec 2022
Source type
Scholarly Journal
Language of publication
Spanish
ProQuest document ID
3108037885
Back to topZ1uPUdKpn2U8MmVODjgY5A==:MlPZxFBwAI87tOCTnERAKStsvUFnCEGLDpgW2nC0WM/li25KcgQjbfnJUnkdJpu58ODeyTlo993NzPczR6X/h+SThJQL+Xiavx94g/rj30j6L3c+GplVuZejEcH1M1cgmAwDbUUdE6Ba00tQQW5uA5CxcbfDlY6v55liCJn7xfGkBnTJhLlG/NHOWTklgaGRsR91Nwp3FVzyvWR/arHwMzaPEaW7g86OtYru7Izn7YVjK8d0NSmGQFB1emksxylg2BxSbXs9vX6XWP/fzno3AgJINrpj0bj8QcpgaX6hd0vQ26gwMdXhsuxf+na/rKvifI5pnWTO2B6CtWkHnzTCdbUs6pyuSqhZTMhoKCpLRWn9CfKgXpsOsH7gp7ERgDydU8buAtqN5OU2OeTq6BZtKw==